60 Degrees Pharmaceuticals, Inc.
- SXTP
- NASDAQ
- Biotechnology
- Infectious Disease Therapies
- Malaria Prophylaxis (Arakoda)
$0.83
Today −3.29%Quote Oct 19, 2026, 08:00 PM UTC
−13.46%over the last month
Max drawdown −42.5%From 1-month high −42.5%3 months −47.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical firm dedicated to developing and bringing to market therapies aimed at preventing and treating infectious diseases within the United States. The company currently offers Arakoda, an approved medication for malaria prophylaxis.
Where the money comes from
Q3 2024 revenue $146,082
- Product$135,29392.6%
- Service$10,7897.4%
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
3
Market value
$2.9M
Quote Oct 19
Floor
$0.81
2.6% below price
Resistance
$0.88
6.9% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SXTPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free